Perimeter Medical Imaging AI to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference

Rhea-AI Summary

Perimeter Medical Imaging AI (OTCQX: PYNKF) will present an update at the 2026 Bloom Burton & Co. Healthcare Investor Conference on April 21, 2026 at 10:00 a.m. ET at the Metro Toronto Convention Centre.

The presentation will be broadcast live and later archived in the company's Investors section under "News/Events."

News Market Reaction – PYNKF

-7.57%

-7.57% Session close to close

In the Apr 14 session, PYNKF declined 7.57%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TORONTO and DALLAS, April 14, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce that management will present an update on the Company's business at the 2026 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 21, 2026 at 10:00 a.m. Eastern Time at the Metro Toronto Convention Centre.

The presentation will also be broadcast live and archived on the Company's website under "News/Events" in the Investors section.

About Perimeter Medical Imaging AI, Inc.

Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Claire™, recently approved by the U.S. Food and Drug Administration (FDA), is our next-generation AI-enabled device. The Company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month.

Indications for Use: The Claire OCT System is an adjunctive three-dimensional imaging tool which provides volumetric cross-sectional, real-time depth visualization, coupled with an artificial intelligence computer-aided detection algorithm which identifies and marks focal areas suspicious for breast cancer. It is used concurrently with physician interpretation of the images. The Claire OCT System is intended for use in conjunction with other standard methods for evaluation of the margins of excised lumpectomy tissue during surgical procedures in patients with a biopsy-confirmed diagnosis of breast cancer.

The Claire OCT System should not be used to replace standard tissue histopathology assessment and should not be used for diagnosis. The device is not intended for use in any of the following individuals: under the age of 18, male, have metastatic cancer (Stage IV), have lobular carcinoma as their primary diagnosis, have had previous ipsilateral breast surgery for benign or malignant disease within two years (including implants and breast augmentation), patients with multi-centric disease (histologically diagnosed cancer in two different quadrants of the breast), unless resected in a single specimen, patients with bilateral disease (diagnosed cancer in both breasts), patients who are currently lactating, patients who are currently pregnant, or concurrent use in surgeries with cryo-assisted localization. Refer to prescriber labeling for full safety information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts

Stephen Kilmer
Investor Relations
Direct: 647-872-4849
Email: skilmer@perimetermed.com 

Susan Thomas
Media Relations
Direct: 619-540-9195
Email: susan@endpointcommunications.net 

Adrian Mendes
Chief Executive Officer
Toll-free: 888-988-7465 (PINK)
Email: investors@perimetermed.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/perimeter-medical-imaging-ai-to-participate-in-the-2026-bloom-burton--co-healthcare-investor-conference-302741280.html

SOURCE Perimeter Medical Imaging AI Inc.

FAQ

When will Perimeter Medical Imaging AI (PYNKF) present at the Bloom Burton 2026 conference?

Perimeter will present on April 21, 2026 at 10:00 a.m. Eastern Time. According to the company, the presentation takes place at the Metro Toronto Convention Centre and is part of the Bloom Burton & Co. Healthcare Investor Conference agenda.

How can investors watch the PYNKF presentation at the April 21, 2026 conference?

Investors can watch a live broadcast of the presentation and view the archive afterward. According to the company, the webcast will be available on the company's website under the Investors section, "News/Events," for later review.

What will Perimeter Medical Imaging AI (PYNKF) cover in its April 21, 2026 conference presentation?

The company will provide a business update and progress overview during the presentation. According to the company, management will discuss recent commercial-stage developments and operational highlights for investor audiences.

Where is the Bloom Burton & Co. Healthcare Investor Conference taking place for the PYNKF presentation?

The conference is held at the Metro Toronto Convention Centre in Toronto. According to the company, Perimeter's presentation is scheduled for April 21, 2026 at 10:00 a.m. Eastern Time and will be open to registered attendees and webcast viewers.

Will the PYNKF conference presentation materials be available after April 21, 2026?

Yes, presentation materials and a replay will be archived on the company's site for later access. According to the company, investors can find the recording and related news under Investors > News/Events on the website.